Back to GetFilings.com



Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 


 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Quarterly Period Ended March 31, 2003

 

Commission File Number 001-11091

 

APOGENT TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)

 

Wisconsin

 

22-2849508

(State or other jurisdiction of

Incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

30 Penhallow Street,  Portsmouth, New Hampshire 03801

(Address of principal executive offices, including zip code)

 

(603) 433-6131

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

YES  x                                NO  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

 

YES  ¨                                NO  x

 

At April 21, 2003, there were 102,194,940 shares of the Registrant’s Common Stock, par value $0.01 per share, outstanding.

 

 



Table of Contents

APOGENT TECHNOLOGIES INC. AND SUBSIDIARIES

FORM 10-Q

QUARTER ENDED MARCH 31, 2003

 

TABLE OF CONTENTS

 

    

Page


PART I—FINANCIAL INFORMATION

    

Item 1: Financial Statements

    

Consolidated Balance Sheets as of March 31, 2003 and September 30, 2002 (unaudited)

  

1

Consolidated Statements of Operations for the Three and Six Months Ended March 31, 2003 and 2002 (unaudited)

  

2

Consolidated Statement of Shareholders’ Equity for the Six Months Ended March 31, 2003 (unaudited)

  

3

Consolidated Statements of Cash Flows for the Six Months Ended March 31, 2003 and 2002 (unaudited)

  

4

Notes to Unaudited Consolidated Financial Statements

  

5

Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

20

             Cautionary Factors

  

31

Item 3: Quantitative and Qualitative Disclosures About Market Risk

    

Item 4: Controls and Procedures

    

PART II—OTHER INFORMATION

    

Item 4: Submission of Matters to a Vote of Security Holders

  

36

Item 6: Exhibits and Reports on Form 8-K

  

36

SIGNATURE

  

37

CERTIFICATIONS

  

38

EXHIBIT INDEX

  

40


Table of Contents

PART I—FINANCIAL INFORMATION

 

Item 1:    Financial Statements

 

APOGENT TECHNOLOGIES INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

(unaudited)

 

    

March 31,

2003


    

September 30,

2002


 
     

ASSETS

                 

Current assets:

                 

Cash and cash equivalents

  

$

17,406

 

  

$

16,327

 

Accounts receivable (less allowance for doubtful accounts of $4,288 and $5,723, respectively)

  

 

176,941

 

  

 

186,950

 

Inventories

  

 

207,308

 

  

 

203,997

 

Deferred income taxes

  

 

14,127

 

  

 

14,127

 

Prepaid expenses and other current assets

  

 

18,442

 

  

 

19,689

 

Assets of discontinued operations—held for sale

  

 

52,404

 

  

 

5,436

 

    


  


Total current assets

  

 

486,628

 

  

 

446,526

 

Available for sale security

  

 

58,579

 

  

 

60,183

 

Property, plant and equipment, net

  

 

266,289

 

  

 

270,893

 

Intangible assets, net

  

 

1,154,949

 

  

 

1,243,113

 

Other assets

  

 

18,285

 

  

 

15,370

 

    


  


Total assets

  

$

1,984,730

 

  

$

2,036,085

 

    


  


LIABILITIES AND SHAREHOLDERS’ EQUITY

                 

Current liabilities:

                 

Short-term debt and overdrafts

  

$

14,026

 

  

$

10,640

 

Current portion of long-term debt

  

 

2,207

 

  

 

25,352

 

Accounts payable

  

 

46,281

 

  

 

53,779

 

Income taxes payable

  

 

49,332

 

  

 

53,064

 

Accrued payroll and employee benefits

  

 

29,243

 

  

 

32,009

 

Accrued interest expense

  

 

16,183

 

  

 

16,630

 

Restructuring reserve

  

 

874

 

  

 

1,548

 

Other current liabilities

  

 

29,452

 

  

 

23,074

 

Liabilities of discontinued operations

  

 

5,338

 

  

 

305

 

    


  


Total current liabilities

  

 

192,936

 

  

 

216,401

 

Long-term debt, less current portion

  

 

697,520

 

  

 

635,020

 

Securities lending agreement

  

 

58,579

 

  

 

60,183

 

Deferred income taxes

  

 

123,400

 

  

 

132,100

 

Other liabilities

  

 

17,028

 

  

 

17,243

 

Commitments and contingent liabilities

  

 

 

  

 

 

Shareholders’ equity:

                 

Preferred stock, $0.01 par value; authorized 20,000,000 shares

  

 

 

  

 

 

Common stock, $0.01 par value; authorized 250,000,000 shares; issued 107,019,535 and 106,976,877 shares, respectively; outstanding 102,194,940, and 105,967,853 shares, respectively

  

 

1,067

 

  

 

1,070

 

Equity rights, 50 rights at $1.09 per right

  

 

 

  

 

 

Additional paid-in capital

  

 

270,627

 

  

 

271,682

 

Retained earnings

  

 

721,142

 

  

 

748,791

 

Accumulated other comprehensive loss

  

 

(13,574

)

  

 

(26,419

)

Treasury common stock, 4,824,595 and 1,009,024 shares at cost

  

 

(83,995

)

  

 

(19,986

)

    


  


Total shareholders’ equity

  

 

895,267

 

  

 

975,138

 

    


  


Total liabilities and shareholders’ equity

  

$

1,984,730

 

  

$

2,036,085

 

    


  


 

See accompanying notes to the unaudited consolidated financial statements.

 

1


Table of Contents

APOGENT TECHNOLOGIES INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

    

Three Months Ended

March 31,


      

Six Months Ended

March 31,


 
    

2003


    

2002


      

2003


    

2002


 

Net sales

  

$

276,638

 

  

$

255,088

 

    

$

534,436

 

  

$

489,062

 

Cost of sales

  

 

145,409

 

  

 

126,757

 

    

 

278,366

 

  

 

246,446

 

Cost of products sold

                                     

Restructuring charges

  

 

 

  

 

3,673

 

    

 

 

  

 

3,673

 

    


  


    


  


Total cost of sales

  

 

145,409

 

  

 

130,430

 

    

 

278,366

 

  

 

250,119

 

    


  


    


  


Gross profit

  

 

131,229

 

  

 

124,658

 

    

 

256,070

 

  

 

238,943

 

Selling, general and administrative expenses

  

 

71,310

 

  

 

63,029

 

    

 

139,940

 

  

 

121,922

 

Restructuring charges

  

 

332

 

  

 

1,614

 

    

 

332

 

  

 

1,614

 

    


  


    


  


Total selling, general and administrative expenses

  

 

71,642

 

  

 

64,643

 

    

 

140,272

 

  

 

123,536

 

    


  


    


  


Operating income

  

 

59,587

 

  

 

60,015

 

    

 

115,798

 

  

 

115,407

 

Other income (expense):

                                     

Interest expense

  

 

(10,381

)

  

 

(10,344

)

    

 

(20,792

)

  

 

(20,578

)

Amortization of deferred financing fees

  

 

(891

)

  

 

(914

)

    

 

(1,803

)

  

 

(1,741

)

Other, net

  

 

289

 

  

 

800

 

    

 

780

 

  

 

2,309

 

    


  


    


  


Income from continuing operations before income taxes

  

 

48,604

 

  

 

49,557

 

    

 

93,983

 

  

 

95,397

 

Income taxes

  

 

17,740

 

  

 

18,138

 

    

 

34,304

 

  

 

34,915

 

    


  


    


  


Income from continuing operations

  

 

30,864

 

  

 

31,419

 

    

 

59,679

 

  

 

60,482

 

Discontinued operations, net of income tax benefit

  

 

(87,246

)

  

 

(12,470

)

    

 

(87,328

)

  

 

(11,562

)

    


  


    


  


Net income (loss)

  

$

(56,382

)